The Arizona Diamondbacks have made a notable addition to their roster by signing outfielder Max Kepler, despite his ongoing suspension for performance-enhancing drug use. Kepler, who has 18 days remaining on his 80-game suspension, will be eligible to return to the field on June 25. This decision comes as the Diamondbacks aim to strengthen their lineup in the competitive National League West.

Kepler’s Career and Suspension

Kepler, a seasoned player with 11 Major League Baseball seasons under his belt, spent the first decade of his career with the Minnesota Twins before playing for the Philadelphia Phillies last season. Known for his power at the plate, Kepler holds a career batting average of .235, with 179 home runs and 560 RBIs. Despite his contributions, his postseason experience is limited, with only 64 at-bats over 16 games.

His suspension, which began in January, was a significant setback, as it sidelined him for a substantial portion of the season. At the time of the suspension, Kepler was a free agent, making his signing with the Diamondbacks a strategic move for both the player and the team.

Impact on the Diamondbacks

The Diamondbacks, currently in second place in the National League West, are 7 1/2 games behind the Los Angeles Dodgers. Kepler’s addition is seen as a potential boost to their offensive capabilities as they strive to close the gap. However, under MLB rules, Kepler will be ineligible to participate in the postseason should the Diamondbacks secure a playoff spot.

This signing reflects the team’s commitment to enhancing their roster and making a strong push in the latter half of the season. Kepler’s experience and skill set are expected to contribute significantly once he returns to active play.

Original reporting: Appleton, WI News Feed (HLL/CB) — read the source article.